Dr Ademola Oyekan consultant radiation and clinical oncologist at the Lagos State University (LASUTH) speaks with Gboyega Alaka on Prostate cancer, why it is rampant among people of black race, plus ...

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

ImmunityBio IBRX shares rallied 27.2% on Thursday after it announced that it has completed the regulatory filing process in the EU and the United Kingdom for Anktiva (nogapendekin alfa inbakicept) in ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

The BAMs have a hydrophobic inner surface to prolong microbubble retention within biofluids and a hydrophilic outer layer ...

A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...

ImmunityBio is at the forefront of developing innovative immunotherapies and cell therapies. The company has a vertically integrated approach, allowing it to oversee every step of development, from ...

Goodyear Tire and Rubber, in Niagara Falls, is being fined $15,000 by the New York State Department of Environmental ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...